Nearly two decades after the…
Nearly two decades after the parties first floated the idea [...]
Nearly two decades after the parties first floated the idea [...]
China’s National Medical Products Administration suspended the import, sale and [...]
The FDA is freeing Intellia’s CRISPR therapy from one of [...]
Ahead of its acquisition by cancer imaging company Kuva Labs, [...]
After posting 16.2% revenue growth in the last financial year, [...]
Four years after listing on the Nasdaq, Genenta Sciences is [...]
The companies had committed to a five-year partnership in July [...]
With Enhertu and Datroway, Daiichi Sankyo has made itself a [...]
What do you get when you insert a molecular glue [...]
Former CytoDyn CEO Nader Pourhassan, Ph.D., has received a 30-month [...]